Exponent, Inc. (EXPO) Q3 FY2026 earnings

Reported results

• GAAP total revenues increased 18% to $173.7 million in the third quarter of 2026 compared to $147.1 million in the third quarter of 2025.
• Revenues before reimbursements increased 12% to $153.1 million in the third quarter of 2026 compared to $137.1 million in the third quarter of 2025.
• GAAP net income increased to $30.9 million, or $0.64 per diluted share, in the third quarter of 2026, compared to $28.0 million, or $0.55 per diluted share, in the third quarter of 2025.
• Non-GAAP EBITDA increased to $45.0 million, or 29.4% of revenues before reimbursements, in the third quarter of 2026, compared to $38.8 million, or 28.3% of revenues before reimbursements, in the third quarter of 2025.
• Non-GAAP EBITDAS for the third quarter of 2026 was $51,670 thousand, compared to $44,178 thousand in the third quarter of 2025.

Guidance

• For the fourth quarter of fiscal 2026 as compared to the same period one year prior, Exponent anticipates revenues before reimbursements to grow 8% to 10%.
• For the fourth quarter of fiscal 2026, Exponent anticipates non-GAAP EBITDA to be 26.3% to 26.8% of revenues before reimbursements.
• For the full fiscal year 2026 as compared to fiscal year 2025, Exponent anticipates revenues before reimbursements to grow 10% to 11%.
• For the full fiscal year 2026, Exponent anticipates non-GAAP EBITDA to be 28.0% to 28.3% of revenues before reimbursements.

Price and volatility reaction

The stock moved +2.5% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -5.1 vol points across the event (constant-maturity series — not the front-week crush).

Source

The figures above come from the earnings release the company filed with the SEC on 2026-10-29 (8-K, Item 2.02). Read the original filing on sec.gov.